首页 正文

Oxaliplatin-flavone pharmaceutical co-crystal-CN111205332A: patent spotlight

{{output}}
Co-crystallization is a technique for modifying physicochemical properties of pharmaceutical ingredients with an aim to enhance the therapeutic efficacy and subsequent reduction in toxicity. The patent describes the development of oxaliplatin co-crystals using... ...